World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
53994
World Ranking
13841
National Ranking
7025

Lori J. Pierce publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lori J. Pierce sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 379 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lori J. Pierce D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lori J. Pierce sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2018 - Member of the National Academy of Medicine (NAM)

Overview

Lori J. Pierce is affiliated with the University of Michigan-Ann Arbor in the United States. Their research primarily focuses on medicine, with significant contributions in biochemistry, genetics, and molecular biology. The scientist has a strong emphasis on oncology and cancer research, particularly in the subfields of pulmonary and respiratory medicine, as well as radiology, nuclear medicine, and imaging. They have also addressed topics related to economics and econometrics within their scientific work.

The scientist's work spans several key topics, including:

  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • Global Cancer Incidence and Screening
  • Economic and Financial Impacts of Cancer
  • Ethics in Clinical Research
  • Estrogen and related hormone effects
  • Health Systems, Economic Evaluations, Quality of Life

Among notable recent papers, the scientist has participated in the publication of key clinical guidelines and meta-analyses in breast cancer, including:

  • Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology, Journal of the National Comprehensive Cancer Network, 2020
  • Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology, Journal of the National Comprehensive Cancer Network, 2022
  • NCCN Guidelines® Insights: Breast Cancer, Version 4.2023, Journal of the National Comprehensive Cancer Network, 2023
  • NCCN Guidelines® Insights: Breast Cancer, Version 4.2021, Journal of the National Comprehensive Cancer Network, 2021
  • Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13,864 women in seven randomized trials, The Lancet Oncology, 2021

Frequent coauthors collaborating with Lori J. Pierce include:

  • Corey Speers
  • Reshma Jagsi
  • Anna R. Michmerhuizen
  • Andrea M. Pesch
  • James A. Hayman

The scientist regularly publishes in prominent venues, with a body of work appearing in:

  • International Journal of Radiation Oncology*Biology*Physics
  • Cancer Research
  • Journal of Clinical Oncology
  • Practical Radiation Oncology
  • Clinical Cancer Research

Lori J. Pierce has received recognition as a Member of the National Academy of Medicine (NAM) in 2018, reflecting their involvement in medicine and oncology research over many years.

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

    S Darby;P McGale;C Correa

  • Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

    C Focan;SM Steinberg;M Blichert-Toft;JF Forbes

  • Clinical practice guidelines in oncology

    William J. Gradishar;Benjamin O. Anderson;Ron Balassanian;Sarah L. Blair

  • Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

    William J. Gradishar;Benjamin O. Anderson;Jame Abraham;Rebecca Aft

  • Regional Nodal Irradiation in Early-Stage Breast Cancer

    Timothy J. Whelan;Ivo A. Olivotto;Wendy R. Parulekar;Ida Ackerman

  • Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer

    Joan A. Jacobson;David N. Danforth;Kenneth H. Cowan;Teresa D'angelo

  • Radiation Dose–Volume Effects in the Brain

    Giovanna Gagliardi;Louis S. Constine;Vitali Moiseenko;Candace Correa

  • Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Bernard Asselain;William Barlow;John Bartlett;Jonas Bergh

  • Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

    J. Bergh;K. Pritchard;K. Albain;S. Anderson

  • Development and Validation of a Heart Atlas to Study Cardiac Exposure to Radiation Following Treatment for Breast Cancer

    Mary Feng;Jean M. Moran;Todd Koelling;Aamer Chughtai

  • Radiation-related heart disease: current knowledge and future prospects.

    Sarah C. Darby;David J. Cutter;Marjan Boerma;Louis S. Constine

  • Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.

    Carolyn Taylor;Candace Correa;Frances K Duane;Marianne C Aznar

  • Breast cancer: Clinical practice guidelines in oncology

    Robert W. Carlson;Benjamin O. Anderson;Harold J. Burstein;Charles E. Cox

  • Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy☆

    Editha A Krueger;Edwin G Wilkins;Myla Strawderman;Paul Cederna

  • NCCN Guidelines® insights breast cancer, version 1.2017: Featured updates to the NCCN Guidelines

    William J. Gradishar;Benjamin O. Anderson;Ron Balassanian;Sarah L. Blair

  • Fractionation for Whole Breast Irradiation: An American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline

    Benjamin D. Smith;Soren M. Bentzen;Candace R. Correa;Carol A. Hahn

  • Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial

    Frank A Vicini;Reena S Cecchini;Julia R White;Douglas W Arthur

  • Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy in BRCA1/2-Associated Stage I/II Breast Cancer

    Lori J. Pierce;Albert M. Levin;Timothy R. Rebbeck;Merav A. Ben-David

  • Variability of Target and Normal Structure Delineation for Breast Cancer Radiotherapy: An RTOG Multi-Institutional and Multiobserver Study

    X. Allen Li;An Tai;Douglas W. Arthur;Thomas A. Buchholz

Frequent Co-Authors

Kent A. Griffith
Kent A. Griffith University of Michigan–Ann Arbor
Reshma Jagsi
Reshma Jagsi University of Michigan–Ann Arbor
Daniel F. Hayes
Daniel F. Hayes University of Michigan–Ann Arbor
Frank A. Vicini
Frank A. Vicini Beaumont Health
Bruce G. Haffty
Bruce G. Haffty Rutgers, The State University of New Jersey
Lawrence B. Marks
Lawrence B. Marks University of North Carolina at Chapel Hill
Harold J. Burstein
Harold J. Burstein Harvard University
William J. Gradishar
William J. Gradishar Northwestern University
Sharon H. Giordano
Sharon H. Giordano The University of Texas MD Anderson Cancer Center
George Somlo
George Somlo City Of Hope National Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine or healthcare, several online degree options can support your career aspirations beyond a traditional MD. Many choose the online master of health administration to develop management skills for hospitals or other healthcare organizations.

Cost is a key concern, so exploring the cheapest online mha programs can help you find quality education at a lower price point. Those with a nursing background might consider the cheapest online bsn to dnp programs to move into advanced nursing roles or leadership positions in clinical care.

If you’re interested in pharmaceuticals, an online pharmacist degree can be a flexible way to enter or advance in pharmacy careers. Each of these online pathways offers diverse career opportunities within the healthcare sector, making them excellent options for students aiming to make a difference without following a traditional medical school route.

Best Scientists Citing Lori J. Pierce

Trending Scientists